Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Long-Term Efficacy and Safety of Obecabtagene Autoleucel (obe-cel) in Adult Patients (pts) with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia ([R/R B-ALL]; Pooled Analysis from ALLCAR19 and FELIX Phase Ib Studies) or Other B-cell Malignancies (ALLCAR19 Extension Study)

Blood (2023) 142 (Supplement 1): 2114.

https://doi.org/10.1182/blood-2023-180666

Published: 2023

Journal Articles

In Vivo Generation of Memory-like NK Cells for the Treatment of AML and Myelodysplastic Syndrome; Early Clinical Applications of INKmune TM

Kim H. Orchard, Helena Ballestero, Aga Zubiak, Chris Dalley, Deborah Susan Richardson, Rob Torrance, Trinity Eales, Dimitra Peppa, May Sabry, Mark W. Lowdell

Blood (2022) 140 (Supplement 1): 4590–4591.

https://doi.org/10.1182/blood-2022-166175

Published: 2022

Journal Articles

Low Toxicity and Disease Responses in Systemic AL-Amyloidosis Using an Yttrium-90 Labelled Anti-CD66 Monoclonal Antibody TLX66 As the Only Conditioning Prior to Autologous Stem Cell Transplantation

Mary Jessel, Kim H. Orchard, Ashutosh D. Wechalekar

Blood (2022) 140 (Supplement 1): 12711–12712.

https://doi.org/10.1182/blood-2022-169646

Published: 2022

Journal Articles

Comparison of Fludarabine/Melphalan (FluMel) with Fludarabine/Melphalan/BCNU or Thiotepa (FBM/FTM) in Patients with AML in First Complete Remission Undergoing Allogeneic Hematopoietic Stem Cell Transplantation - a Registry Study on Behalf of the EBMT Acute Leukemia Working Party

Blood (2022) 140 (Supplement 1): 2110–2112.

https://doi.org/10.1182/blood-2022-162277

Published: 2022

Journal Articles

Autologous Stem Cell Transplantation in AL-Amyloidosis Following Yttrium-90 Labelled Anti-CD66 Monoclonal Antibody As Sole Conditioning Is Associated with Low Toxicity and Demonstrable Disease Responses

Kim H. Orchard, Jon Langford, Paul Lloyd-Evans, Denise Phillips, Matthew Guy, Sofia Michopoulou, Gemma Lewis, Julian Williams, Clint Zvavamwe, Claire Hutchison, Jane Nunnick, Amanda Blackwell, Pei-San Chan, Caspar Wickham, Ann-Marie Quigley, Mark Cook, Graham Jackson, Philip N Hawkins, Ashutosh D. Wechalekar

Blood (2021) 138 (Supplement 1): 3819.

https://doi.org/10.1182/blood-2021-146300

Published: 2021

Journal Articles

COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)

Per Ljungman, MD PhD, Rafael De La Camara, MD, Malgorzata Mikulska, Gloria Tridello, Beatriz Aguado, MD, Yves Beguin, MD PhD, Rodrigo Martino Bufarull, Fabio Ciceri, MD, Lucía López Corral, MD, Claudia Crippa, MD, Dries Deeren, MD PhD, Rafael F. Duarte, MD PhD FRCP, María Laura Fox, Anna Grassi, MD, María-José Jimenez, MD, Safiye Koculu, MD, Mi Kwon, MD PhD, Juan Carlos Vallejo Llamas, Jose Luiz Lopez Lorenzo, MD, Stephan Mielke, MD, Javier López Jiménez, MD PhD, Zoraida Mesa Morales, Kim H. Orchard, MBBS,PhDFRCP,FRCPath, Rocio Parody Porras, Victoria Potter, MBBS, BSc, FRACP, FRCPA, María Suárez-Lledó, MD, Nicolaas Schaap, MD PhD, Celestine Simand, MD, Luisa Sisinni, MD, John A Snowden, MD PhD, Daniele Vallisa, MD, Ipek Yonalhindilerden, Alienor Xhaard, MD, Nina Simone Knelange, Angel Cedillo, Nicolaus Kröger, MD, Jose Luis Piñana Sanchez, Jan Styczynski, MD PhD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-138732

Published: 2020

Journal Articles

Allogeneic Stem Cell Transplantation (alloHSCT) for Chronic Lymphocytic Leukemia (CLL) in the Era of Novel Agents

Lindsey E. Roeker, MD, Jennifer R. Brown, MD PhD, Peter Dreger, Oscar B Lahoud, MD, Toby A. Eyre, MBBChir, MRCP, Danielle M. Brander, MD, Alan Skarbnik, MD, Catherine C. Coombs, MD, Haesook T. Kim, PhD, Steven T Manchini, BS, Timothy J Voorhees, MD, Kim H. Orchard, MBBS,PhDFRCP,FRCPath, Harriet S Walter, Arvind K. Arumainathan, FRCPath, MBBS, MRCP,, Andrea Sitlinger, MD, Craig S. Sauter, MD, Sergio A Giralt, MD, Miguel-Angel Perales, MD, Anthony R. Mato, MDMSCE

Blood (2019) 134 (Supplement_1): 3321.

https://doi.org/10.1182/blood-2019-124140

Published: 2019

Journal Articles

Comorbidity-Associated Risk of Overall Mortality Following Hematopoietic Stem-Cell Transplantation Is Regimen-Dependent: A Study from the Acute Leukemia Working Party of the EBMT

Joshua Fein, Myriam Labopin, MD, Roni Shouval, MD PhD, Gerard Socie, MD PhD, Jürgen Finke, MD, Jan J Cornelissen, MD PhD, Ram Malladi, Maija Itälä-Remes, MD PhD, Patrice Chevallier, MD, Kim H. Orchard, MBBS,PhDFRCP,FRCPath, Donald Bunjes, MD, Mahmoud Aljurf, MD, Marie Thérèse Rubio, MD, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2018) 132 (Supplement 1): 203.

https://doi.org/10.1182/blood-2018-99-113296

Published: 2018

Journal Articles

CMV~IMPACT: Results of a Randomized Controlled Trial of Immuno-Prophylactic Adoptive Cellular Therapy following Sibling Donor Allogeneic HSCT

Karl S Peggs, Eleni Tholouli, Ronjon Chakraverty, PhD, Emmanouil Nikolousis, PhD, Adrian Bloor, PhD FRCPath, Stephen Devereux, MD PhD FRCPath, Kim H. Orchard, PhD, Charles Crawley, Anne Parker, Stephen P Robinson, PhD, Frederick Chen, MDPhD, Gordon Cook, MD, Richard E Clark, MBBS MD, Kirsty Thomson, Matthew Cobb, Katy Newton, PhD, Simon Thomas, PhD, Paul Moss, PhD

Blood (2014) 124 (21): 1109.

https://doi.org/10.1182/blood.V124.21.1109.1109

Published: 2014

Journal Articles

Biosimilar G-CSF Based Mobilization Of Peripheral Blood Hematopoietic Stem Cells For Autologous and Allogeneic Stem Cell Transplantation

Michael Schmitt, MD, Amy Publicover, MB BS MRCP FRCPath, Kim H. Orchard, MD, Anita Schmitt, MD, Panagiotis Tsirigotis, MD, Reeba Kuriakose, RN, Arnon Nagler, MD

Blood (2013) 122 (21): 5444.

https://doi.org/10.1182/blood.V122.21.5444.5444

Published: 2013

Journal Articles

The Genomic Landscape of Myeloproliferative Neoplasms: Somatic Calr Mutations in the Majority of JAK2-Wildtype Patients

Jyoti Nangalia, MBBChir FRCPath, Charles Massie, PhD, E Joanna Baxter, PhD, Francesca L Nice, MRes, Gunes Gundem, PhD, David Wedge, PhD, Edward Avezov, PhD, Juan Li, PhD, Karoline Kollmann, PhD, David G. Kent, PhD, Athar Aziz, PhD, Anna L Godfrey, BMBCh FRCPath, Jonathan Hinton, MSc, Inigo Martincorena, PhD, Peter Van Loo, PhD, Amy V Jones, PhD, Paola Guglielmelli, PhD MD, Patrick Tarpey, PhD, Heather P Harding, PhD, John D Fitzpatrick, BA, Calum T Goudie, BA, Christina A Ortmann, MD, Stephen J Loughran, PhD, Keiran Raine, MSc, David Jones, MSc, Adam Butler, MSc, Jon W Teague, MSc, Sarah O'Meara, Stuart McLaren, Michele Bianchi, Yvonne Silber, MSc, Danai Dimitropolou, BSc, David Bloxham, MSc FRCPath, Laura J Mudie, BSc, Mark Maddison, BSc, Ben Robinson, BSc, Clodagh Keohane, MD, Cathy MacLean, MSc, Kate Hill, BM BS, Kim H. Orchard, MBBS, PhD, FRCP, FRCPath, Sudhir Tauro, PhD, Ming-Qing Du, MB, PhD, Mel Greaves, PhD, FRS, David Bowen, MD, PhD, Brian Huntly, MBChB FRCPath PhD, Claire N Harrison, DM, FRCP, FRCPath, Nicholas C.P. Cross, PhD, FRCPath, David Ron, MD, Alessandro M Vannucchi, MD, Elli Papaemmanuil, PhD, Peter J. Campbell, PhD, Anthony R Green, FRCPath FMedSci

Blood (2013) 122 (21): LBA-2.

https://doi.org/10.1182/blood.V122.21.LBA-2.LBA-2

Published: 2013

Journal Articles

Secondary Malignancies After Autologous Stem Cell Transplantation In Patients With Relapsed / Refractory Hodgkin´s Lymphoma. A Retrospective Analysis On Behalf Of The Lymphoma Working Party Of The European Society For Blood and Marrow Transplantation (EBMT)

Anna Sureda, MD, Ariane Boumendil, PhD, Michal Sieniawski, MD, Kirsty Thomson, MD, Martin Gramatzki, MD, Didier Blaise, Catherine Thieblemond, MD, Charles Crawley, MD, Marc Renaud, MD, Patrice Chevalier, MD, Jian Jian Luan, Kim H. Orchard, MD, Paneesha Shankara, MD, Urs Schanz, MD, Norbert Schmitz, Peter Dreger, MD

Blood (2013) 122 (21): 4636.

https://doi.org/10.1182/blood.V122.21.4636.4636

Published: 2013

Journal Articles

Immune Reconstitution Following the Use of Targeted Radiotherapy for Reduced Intensity Conditioning in Allogeneic Stem Cell Transplantation: A Single Centre Experience

Amy Publicover, MB BS MRCP FRCPath, Deborah S. Richardson, MD, FRCP, FRCPath, MA, MBBChir, Efrem Eren, Kate Hill, Elizabeth Hodges, Carol Hurlock, Sara Main, Nikki McKeag, Joan Newman, Theresa Schneider, MD, Kim H. Orchard, MBBS, PhD, FRCP, FRCPath

Blood (2012) 120 (21): 4489.

https://doi.org/10.1182/blood.V120.21.4489.4489

Published: 2012

Journal Articles

Early Experience with Clofarabine Pre-Conditioning Prior to Full Intensity or Reduced Toxicity Allogeneic Stem Cell Transplantation: A Promising New Therapy for the Treatment of Refractory Acute Leukaemia

Deborah S. Richardson, MD, FRCP, FRCPath, MA, MBBChir, Amy Publicover, MB BS MRCP FRCPath, Kate Hill, Carol Hurlock, Joan Newman, Nikki McKeag, Sara Main, Harriet Launders, Kim H. Orchard, MBBS, PhD, FRCP, FRCPath

Blood (2012) 120 (21): 4511.

https://doi.org/10.1182/blood.V120.21.4511.4511

Published: 2012

Journal Articles

Sustained Complete Metabolic Remission After Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE).

Joerg Halter, WM Michael Schuepbach, Carlo Casali, Ronit Elhasid, Keith Fay, Simon Hammans, Isabel Illa, Liliane Kappeler, Stephan Kraehenbuehl, Thomas Lehmann, Hanna Mandel, Ramon Marti, Heinrich Mattle, Kim H. Orchard, David Savage, Carolyn Sue, David Valcárcel, Alois Gratwohl, Michio Hirano

Blood (2009) 114 (22): 1181.

https://doi.org/10.1182/blood.V114.22.1181.1181

Published: 2009

Journal Articles

A Comparison of Conditioning Regimens with or without Alemtuzumab for Sibling RIC Transplants for AML: Study from the British Society for Blood and Marrow Transplantation.

Ram K. Malladi, MD, Andrew J. Peniket, MD, Timothy James Littlewood, MD, Keiren E. Towlson, MSc SRN, Rachel Pearce, John Yin, MD, Jamie D. Cavanagh, MD, Charles Craddock, MD, Kim H. Orchard, MD, David I. Marks, MD

Blood (2006) 108 (11): 3002.

https://doi.org/10.1182/blood.V108.11.3002.3002

Published: 2006

NARROW

Long-Term Efficacy and Safety of Obecabtagene Autoleucel (obe-cel) in Adult Patients (pts) with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia ([R/R B-ALL]; Pooled Analysis from ALLCAR19 and FELIX Phase Ib Studies) or Other B-cell Malignancies (ALLCAR19 Extension Study)

In Vivo Generation of Memory-like NK Cells for the Treatment of AML and Myelodysplastic Syndrome; Early Clinical Applications of INKmune TM

Low Toxicity and Disease Responses in Systemic AL-Amyloidosis Using an Yttrium-90 Labelled Anti-CD66 Monoclonal Antibody TLX66 As the Only Conditioning Prior to Autologous Stem Cell Transplantation

Comparison of Fludarabine/Melphalan (FluMel) with Fludarabine/Melphalan/BCNU or Thiotepa (FBM/FTM) in Patients with AML in First Complete Remission Undergoing Allogeneic Hematopoietic Stem Cell Transplantation - a Registry Study on Behalf of the EBMT Acute Leukemia Working Party

Autologous Stem Cell Transplantation in AL-Amyloidosis Following Yttrium-90 Labelled Anti-CD66 Monoclonal Antibody As Sole Conditioning Is Associated with Low Toxicity and Demonstrable Disease Responses

COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)

Allogeneic Stem Cell Transplantation (alloHSCT) for Chronic Lymphocytic Leukemia (CLL) in the Era of Novel Agents

Comorbidity-Associated Risk of Overall Mortality Following Hematopoietic Stem-Cell Transplantation Is Regimen-Dependent: A Study from the Acute Leukemia Working Party of the EBMT

CMV~IMPACT: Results of a Randomized Controlled Trial of Immuno-Prophylactic Adoptive Cellular Therapy following Sibling Donor Allogeneic HSCT

Biosimilar G-CSF Based Mobilization Of Peripheral Blood Hematopoietic Stem Cells For Autologous and Allogeneic Stem Cell Transplantation

The Genomic Landscape of Myeloproliferative Neoplasms: Somatic Calr Mutations in the Majority of JAK2-Wildtype Patients

Secondary Malignancies After Autologous Stem Cell Transplantation In Patients With Relapsed / Refractory Hodgkin´s Lymphoma. A Retrospective Analysis On Behalf Of The Lymphoma Working Party Of The European Society For Blood and Marrow Transplantation (EBMT)

Immune Reconstitution Following the Use of Targeted Radiotherapy for Reduced Intensity Conditioning in Allogeneic Stem Cell Transplantation: A Single Centre Experience

Early Experience with Clofarabine Pre-Conditioning Prior to Full Intensity or Reduced Toxicity Allogeneic Stem Cell Transplantation: A Promising New Therapy for the Treatment of Refractory Acute Leukaemia

Sustained Complete Metabolic Remission After Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE).

A Comparison of Conditioning Regimens with or without Alemtuzumab for Sibling RIC Transplants for AML: Study from the British Society for Blood and Marrow Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only